Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins employs more than 30,000 employees across around 375 laboratories in 41 countries and has about EUR 2.54 billion annual revenues (2017).
The Eurofins Group offers a portfolio of over 130,000 reliable analytical methods for characterizing the safety, identity, purity, composition, authenticity and origin of products and biological substances. Through research and development, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical sciences.
Eurofins pursued an aggressive strategy of expansion, buying more than eighty competitors worldwide since it was founded. Notable examples include the acquisition in 2005 of the German company MWG-Biotech and in 2011 of the US company Lancaster Laboratories the latter being acquired for 150 million euros.
